Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06795022 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 304 participants |
| Active Locations | 7 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT06795022 is currently recruiting participants. This phase1 study for hepatocellular carcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06795022 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06795022 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.